STJ  St. Jude Medical Inc.

Exchange

NYSE

Sector

Health Care

Industry

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Cap.

19.63B

Vuru Grade

66.32/100

Current Price

$69.67
+0.99 (+1.44%)

Growth Price

$54.13
Overvalued by 22.31%

Stability Price

$20.56
Overvalued by 70.49%

Company Metrics

  • P/E 19.42
  • P/S 3.48
  • P/B 5.03
  • EPS 3.59
  • Cash ROIC 14.54%
  • Cash Ratio 0.54
  • Dividend 0.29 / 1.64 %
  • Avg. Vol. 1.64M
  • Shares 281.76M
  • Market Cap. 19.63B

Company Description

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantab... more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

St. Jude Medical Given "Market Perform" Rating at Oppenheimer (STJ)
Dakota Financial News - 3 hours ago
They currently have a $79.00 target price on the medical technology company's stock. Oppenheimer's price objective would suggest a potential upside of 15.04% from the stock's current price.
St Jude Medical Inc (NYSE:STJ) Could Be Positioned for a Slump - Markets Wired
Evercore ISI Reiterated St. Jude Medical (NYSE:STJ) As "hold"; Has Target ... - OctaFinance.com
St. Jude Medical (STJ) Stock Gains on Denied Report of Abbott Takeover Bid
TheStreet.com - Aug 27, 2015
"We rate ST JUDE MEDICAL INC (STJ) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate.
Abbott Denies Report It's Preparing Bid for St. Jude Medical - Bloomberg
St. Jude Medical, Inc. (NYSE:STJ) report that Abbott Laboratories (ABT) is ... - Inside Trade
St. Jude Medical's Leadless II & FAME Trial Results Positive
Zacks.com - Sep 1, 2015
Manufacturer and distributor of cardiovascular medical devices, St. Jude Medical Inc. (STJ - Analyst Report) recently presented positive results from two trials - Leadless II and FAME.
Healthcare Stocks News Buzz - St. Jude (STJ), Horizon (HZNP), Sucampo (SCMP ... - Techsonian (press release)
Pre-Market Gainers: St. Jude Medical, Inc, Applied Genetic Technologies Corp ...
Bidness ETC - Aug 27, 2015
However, according to Bloomberg, Abbott spokesman mentioned that the company is not making any offer to St. Jude. The stock started to pull back after Bloomberg's report, as it is currently trading up 4.92% at $72.75, as of 9:33 AM EDT.
St. Jude Medical Wins CE Mark Approval for Prodigy MRI
Zacks.com - Aug 25, 2015
In conjunction with the approval for the Prodigy MRI system, St. Jude Medical seeks to achieve updated labeling in major markets around the world for supplementary chronic pain products.
Bubbly Stocks in Focal Point: St. Jude Medical Inc. (NYSE:STJ), Lockheed ... - StreetWise Report
Abbott Laboratories Preparing $25 Billion Bid for St. Jude Medical -FT
Nasdaq - Aug 27, 2015
Abbott Laboratories (AST) is preparing a stock and cash offer likely of around $25 billion for St. Jude Medical Inc.
St Jude Medical is Oversold
Nasdaq - Aug 21, 2015
But making St Jude Medical Inc an even more interesting and timely stock to look at, is the fact that in trading on Friday, shares of STJ entered into oversold territory, changing hands as low as $68.04 per share.
St. Jude Medical Receives CE Mark for Industry's Only MR-Conditional ...
MarketWatch - Aug 24, 2015
PAUL, Minn., Aug 24, 2015 (BUSINESS WIRE) -- St. Jude Medical, Inc. STJ, -2.49% a global medical device company, today announced CE Mark approval for magnetic resonance imaging (MRI) conditional labeling for the company's Prodigy MRI™ chronic ...
St. Jude: CE Mark For MR-Conditional Rechargeable Spinal Cord Stimulator - Nasdaq
St. Jude Medical, Inc. Price Target Update
Money Flow Index - Aug 21, 2015
St. Jude Medical, Inc. (NYSE:STJ): 17 Brokerage firm Analysts have agreed with the mean estimate for the short term price target of $81.71 in St. Jude Medical, Inc. (NYSE:STJ). However, the stock price could fluctuate by $ 7.01 from the estimate as it ...
St. Jude Medical, Inc. (NYSE:STJ) Ratings Update - Investor Newswire
St. Jude Medical Stock Rating Lowered by Zacks (STJ) - sleekmoney
St. Jude Medical Appoints David Dvorak to Its Board of Directors
KSL.com - Aug 5, 2015
ST. PAUL, Minn.--(BUSINESS WIRE)--Aug 5, 2015--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the appointment of David C. Dvorak - President and Chief Executive Officer of Zimmer Biomet - to its Board of ...
Shares of St. Jude Medical, Inc. (NYSE:STJ) Sees Large Inflow of Net Money Flow - Insider Trading Report